Skip to content

Startup & venture capital news

Multiply Labs raises USD 75m for robotic drug manufacturing

Patrick Soon-Shiong and NantWorks lead the Series B

By /

LinkedInX
Multiply Labs team members gathered around a screen in an office.
Multiply Labs official team page. Photographer and licence not stated.

Multiply Labs publicly announced a USD 75 million Series B on Tuesday 6 October 2026, led by Patrick Soon-Shiong with NantWorks. Fred Parietti's San Francisco team builds robotic systems for biologic drug manufacturing, integrating equipment already used in pharmaceutical laboratories. The company plans to expand manufacturing capacity, advance its product roadmap and grow its engineering, regulatory and business teams. Its clusters automate timed, repetitive steps while allowing drug manufacturers to retain control of production. The investment targets a practical constraint in medicine: manufacturing capacity must develop alongside drug discovery if new therapies are to reach patients at the required scale.

Keep reading

More Funding

All stories